drugset / Trial / NCT07845071
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of cebranopadol in treating acute pain.
Timeline
- Start
- 2026-09-22
- Primary completion
- 2027-01
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cebranopadol | Small molecule | 400 ug | — |
Indications
No indication recorded.